Rigel Pharmaceuticals, Inc. Gains 41.09%
Wed, May 17, 2023 at 07:44 PM
Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ) rocketted at $1.82, representing a gain of 41.1%. On Wed, May 17, 2023, RIGL:NASDAQ hit a New 2-Week High of $1.82. The stock appeared on our News Catalysts scanner on Sun, May 14, 2023 at 06:11 PM in the 'MISCELLANEOUS' category. From Wed, May 03, 2023, the stock recorded 70.00% Up Days and 72.73% Green Days
The stock spiked on Fri, Jan 20, 2023 at $2.04 with a volume of 3M+.
About Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ)
Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company. It discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
Top 10 Gainers:
- Aspen Group, Inc. (ASPU:NASDAQ), 179.3%
- Immutep Limited (IMMP:NASDAQ), 64.78%
- Peak Bio Inc Com (PKBO:NASDAQ), 48.12%
- National Western Life Group, Inc. (NWLI:NASDAQ), 46.32%
- Smart for Life Inc. (SMFL:NASDAQ), 44.4%
- SelectQuote Inc. (SLQT:NYSE), 41.67%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 41.09%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 38.75%
- Viracta Therapeutics Inc. (VIRX:NASDAQ), 37.35%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 36.71%